BIOTIME INC 8-K 6-30-2015

Company

Lineage Cell Therapeutics, Inc.

Filed

July 2, 2015

Period of Report

June 30, 2015

Accession Number

0001140361-15-026611

An 8-K is a current report used to announce material events that shareholders should know about — such as earnings releases, mergers, executive changes, or bankruptcy. Learn more about 8-K filings →